NASDAQ:MRNS - Marinus Pharmaceuticals News Headlines

Sign in or create an account to add this stock to your watchlist.
$3.98 +0.16 (+4.19 %)
(As of 03/26/2019 04:00 PM ET)
Previous Close$3.82
Today's Range$3.83 - $3.99
52-Week Range$2.36 - $10.54
Volume373,868 shs
Average Volume782,003 shs
Market Capitalization$209.03 million
P/E Ratio-4.42
Dividend YieldN/A
Beta3.2

Headlines

Marinus Pharmaceuticals (NASDAQ MRNS) News Headlines

Source:
DateHeadline
Implied Volatility Surging for Marinus Pharmaceuticals (MRNS) Stock OptionsImplied Volatility Surging for Marinus Pharmaceuticals (MRNS) Stock Options
finance.yahoo.com - March 19 at 7:34 PM
Marinus Pharmaceuticals Inc to Post FY2019 Earnings of ($0.89) Per Share, Cantor Fitzgerald Forecasts (MRNS)Marinus Pharmaceuticals Inc to Post FY2019 Earnings of ($0.89) Per Share, Cantor Fitzgerald Forecasts (MRNS)
www.americanbankingnews.com - March 15 at 7:53 AM
Analysts Offer Predictions for Marinus Pharmaceuticals Incs Q3 2019 Earnings (MRNS)Analysts Offer Predictions for Marinus Pharmaceuticals Inc's Q3 2019 Earnings (MRNS)
www.americanbankingnews.com - March 15 at 7:51 AM
Analysts Offer Predictions for Marinus Pharmaceuticals Incs Q1 2019 Earnings (MRNS)Analysts Offer Predictions for Marinus Pharmaceuticals Inc's Q1 2019 Earnings (MRNS)
www.americanbankingnews.com - March 14 at 6:44 AM
Marinus Pharmaceuticals Inc Expected to Post Q1 2019 Earnings of ($0.22) Per Share (MRNS)Marinus Pharmaceuticals Inc Expected to Post Q1 2019 Earnings of ($0.22) Per Share (MRNS)
www.americanbankingnews.com - March 14 at 6:43 AM
Marinus Pharmaceuticals (MRNS) Posts  Earnings Results, Beats Estimates By $0.02 EPSMarinus Pharmaceuticals (MRNS) Posts Earnings Results, Beats Estimates By $0.02 EPS
www.americanbankingnews.com - March 12 at 9:59 AM
Marinus Pharmaceuticals Provides Business Update and 2018 Financial Results - GlobeNewswireMarinus Pharmaceuticals Provides Business Update and 2018 Financial Results - GlobeNewswire
www.globenewswire.com - March 11 at 7:33 PM
Marinus Pharmaceuticals Provides Business Update and 2018 Financial ResultsMarinus Pharmaceuticals Provides Business Update and 2018 Financial Results
finance.yahoo.com - March 11 at 8:41 AM
Research Analysts Issue Forecasts for Marinus Pharmaceuticals Incs FY2018 Earnings (MRNS)Research Analysts Issue Forecasts for Marinus Pharmaceuticals Inc's FY2018 Earnings (MRNS)
www.americanbankingnews.com - March 7 at 6:43 AM
Jefferies Financial Group Comments on Marinus Pharmaceuticals Incs Q2 2019 Earnings (MRNS)Jefferies Financial Group Comments on Marinus Pharmaceuticals Inc's Q2 2019 Earnings (MRNS)
www.americanbankingnews.com - March 6 at 8:34 AM
Andrew TsaiAndrew Tsai
www.benzinga.com - March 6 at 8:34 AM
Marinus up 11% premarket on late-stage study of ganaxolone in rare type of epilepsyMarinus up 11% premarket on late-stage study of ganaxolone in rare type of epilepsy
seekingalpha.com - March 6 at 8:34 AM
Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related EpilepsyMarinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
finance.yahoo.com - March 6 at 8:34 AM
Benzingas Top Upgrades, Downgrades For March 5, 2019 - BenzingaBenzinga's Top Upgrades, Downgrades For March 5, 2019 - Benzinga
www.benzinga.com - March 5 at 6:50 PM
Marinus Pharmaceuticals to Present at the Cowen Healthcare Conference - GlobeNewswireMarinus Pharmaceuticals to Present at the Cowen Healthcare Conference - GlobeNewswire
globenewswire.com - March 5 at 6:50 PM
Jefferies Sees Opportunity In Marinus Pharmaceuticals: 4 Reasons WhyJefferies Sees Opportunity In Marinus Pharmaceuticals: 4 Reasons Why
finance.yahoo.com - March 5 at 6:50 PM
Jefferies Financial Group Initiates Coverage on Marinus Pharmaceuticals (MRNS)Jefferies Financial Group Initiates Coverage on Marinus Pharmaceuticals (MRNS)
www.americanbankingnews.com - March 5 at 11:07 AM
Marinus Pharmaceuticals to Present at the Cowen Healthcare ConferenceMarinus Pharmaceuticals to Present at the Cowen Healthcare Conference
finance.yahoo.com - March 5 at 8:52 AM
Marinus Pharmaceuticals Inc (MRNS) Given Average Recommendation of "Buy" by AnalystsMarinus Pharmaceuticals Inc (MRNS) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - March 4 at 1:40 AM
Marinus Pharmaceuticals Inc (MRNS) Expected to Post Earnings of -$0.30 Per ShareMarinus Pharmaceuticals Inc (MRNS) Expected to Post Earnings of -$0.30 Per Share
www.americanbankingnews.com - March 3 at 11:18 PM
Marinus Announces Leadership TransitionMarinus Announces Leadership Transition
finance.yahoo.com - February 26 at 6:36 PM
Main Line biopharm CEO stepping downMain Line biopharm CEO stepping down
finance.yahoo.com - February 26 at 6:36 PM
Marinus Pharmaceuticals to Present at the Leerink Healthcare ConferenceMarinus Pharmaceuticals to Present at the Leerink Healthcare Conference
finance.yahoo.com - February 20 at 8:38 AM
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - January 25 at 6:04 PM
Marinus Has A Long And Difficult Road Ahead In Postpartum DepressionMarinus Has A Long And Difficult Road Ahead In Postpartum Depression
seekingalpha.com - December 15 at 8:23 AM
Heres Why Marinus Pharmaceuticals Is Sinking Today - Motley FoolHere's Why Marinus Pharmaceuticals Is Sinking Today - Motley Fool
www.fool.com - December 14 at 5:36 PM
Marinus Pharmaceuticals plans $45M stock saleMarinus Pharmaceuticals plans $45M stock sale
finance.yahoo.com - December 13 at 5:36 PM
Marinus Pharmaceuticals Inc.Marinus Pharmaceuticals Inc.
www.barrons.com - December 13 at 9:56 AM
How Marinus Pharma Is Capitalizing on Its Depression Study SuccessHow Marinus Pharma Is Capitalizing on Its Depression Study Success
247wallst.com - December 13 at 9:56 AM
Heres Why Marinus Pharmaceuticals Is Sinking TodayHere's Why Marinus Pharmaceuticals Is Sinking Today
finance.yahoo.com - December 13 at 9:56 AM
Marinus Pharmaceuticals prices common stock offeringMarinus Pharmaceuticals prices common stock offering
seekingalpha.com - December 13 at 9:56 AM
Here's Why Marinus Pharmaceuticals Is Sinking TodayHere's Why Marinus Pharmaceuticals Is Sinking Today
finance.yahoo.com - December 13 at 9:56 AM
Marinus Pharmaceuticals Announces Pricing of Public Offering of Common StockMarinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - December 13 at 9:56 AM
Marinus Pharmas Postpartum Depression Candidate Aces Midstage Trials (NASDAQ:MRNS) - BenzingaMarinus Pharma's Postpartum Depression Candidate Aces Midstage Trials (NASDAQ:MRNS) - Benzinga
www.benzinga.com - December 12 at 4:12 PM
Teligent leads healthcare gainers; Neurocrine Biosciences and Marinus Pharmaceuticals among losers - Seeking AlphaTeligent leads healthcare gainers; Neurocrine Biosciences and Marinus Pharmaceuticals among losers - Seeking Alpha
seekingalpha.com - December 12 at 4:12 PM
Marinus Pharmaceuticals Announces Positive Ganaxolone Data in Women With Postpartum Depression - GlobeNewswireMarinus Pharmaceuticals Announces Positive Ganaxolone Data in Women With Postpartum Depression - GlobeNewswire
globenewswire.com - December 12 at 4:12 PM
Marinus Pharmaceuticals Announces Public Offering of Common Stock - GlobeNewswireMarinus Pharmaceuticals Announces Public Offering of Common Stock - GlobeNewswire
globenewswire.com - December 12 at 4:12 PM
Marinus Shows Impressive Data In Depression StudiesMarinus Shows Impressive Data In Depression Studies
seekingalpha.com - December 11 at 9:02 AM
Marinus Gains on Positive Postpartum ResultsMarinus Gains on Positive Postpartum Results
www.baystreet.ca - December 10 at 5:24 PM
Marinus Scores Big With Midstage Depression StudyMarinus Scores Big With Midstage Depression Study
247wallst.com - December 10 at 5:24 PM
Marinus Pharmas Postpartum Depression Candidate Aces Midstage TrialsMarinus Pharma's Postpartum Depression Candidate Aces Midstage Trials
finance.yahoo.com - December 10 at 5:24 PM
Marinus Pharmas ganaxolone shows positive action in mid-stage postpartum depression studies; shares up 35% premarketMarinus Pharma's ganaxolone shows positive action in mid-stage postpartum depression studies; shares up 35% premarket
seekingalpha.com - December 10 at 8:21 AM
Marinus Pharmaceuticals Announces Positive Ganaxolone Data in Women With Postpartum DepressionMarinus Pharmaceuticals Announces Positive Ganaxolone Data in Women With Postpartum Depression
finance.yahoo.com - December 10 at 8:21 AM
Options Traders Expect Huge Moves in Marinus Pharmaceuticals (MRNS) StockOptions Traders Expect Huge Moves in Marinus Pharmaceuticals (MRNS) Stock
www.zacks.com - December 7 at 8:26 AM
Emboldened By Sages Zulresso Slip, Marinus Is Set To Succeed In PPD And Orphan EpilepsyEmboldened By Sage's Zulresso Slip, Marinus Is Set To Succeed In PPD And Orphan Epilepsy
seekingalpha.com - December 5 at 8:25 AM
Marinus Pharmaceuticals Phase 2 clinical trial in pediatric genetic epilepsies shows positive dataMarinus Pharmaceuticals Phase 2 clinical trial in pediatric genetic epilepsies shows positive data
seekingalpha.com - December 4 at 5:32 PM
Marinus Pharma (MRNS) Phase 2 Data Show L-T Effectiveness of Ganaxolone in Reducing Seizure Frequency in CDKL5 Deficiency Disorder PatientsMarinus Pharma (MRNS) Phase 2 Data Show L-T Effectiveness of Ganaxolone in Reducing Seizure Frequency in CDKL5 Deficiency Disorder Patients
www.streetinsider.com - December 4 at 8:34 AM
Marinus Pharmaceuticals Phase 2 Clinical Trial Data Show Long-term Effectiveness of Ganaxolone in Reducing Seizure Frequency in CDKL5 Deficiency Disorder PatientsMarinus Pharmaceuticals Phase 2 Clinical Trial Data Show Long-term Effectiveness of Ganaxolone in Reducing Seizure Frequency in CDKL5 Deficiency Disorder Patients
finance.yahoo.com - December 4 at 8:34 AM
Is the Options Market Predicting a Spike in Marinus Pharmaceuticals (MRNS) Stock?Is the Options Market Predicting a Spike in Marinus Pharmaceuticals (MRNS) Stock?
www.zacks.com - November 6 at 8:26 AM
Marinus Pharmaceuticals misses by $0.06Marinus Pharmaceuticals misses by $0.06
seekingalpha.com - October 29 at 8:28 AM
This page was last updated on 3/26/2019 by MarketBeat.com Staff

Featured Article: What is a back-end load?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel